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IntrOductIOn
Osteoporosis is a serious, metabolic bone disorder that leads to 
increased susceptibility to fractures and decreased mechanical 
strength of the bones. Osteoporosis is a silent disease that is 
developed in millions of the people worldwide. Since osteoporosis is 
asymptomatic unless a fracture occurs, it is called silent thief [1-3].
It was estimated that over 200 million people suffer from 
osteoporosis around the world [4]. Osteoporosis-associated 
fractures impose a considerable economic burden on health system 
and this disease, if left untreated, results in serious and grueling 
outcomes [5]. It was reported that the worldwide annual incidence 
of hip fracture was about 1.7 milion in 1992 [4]. Approximately 30% 
of all postmenopausal women have had osteoporosis in the United 
States and Europe. It was stated that the risk of hip fracture in these 
countries was even more than the risk of breast cancer in 2001 [6]. 
Studies on Asian women have indicated that bone density is lower 
in these women compared to European and the U.S women [7]. 
The highest prevalence of osteoporosis is observed in the elderly, 
particularly women, such that the investigations have demonstrated 
that women develop osteoporosis four times higher than men, but 
sometimes this disease has occurred in skeletal growth period and 
even adolescence [8].
Osteoporosis is a multifactorial disease and is related to interaction 
between genetic and environmental factors. The study of potential 
genetic predisposition to osteoporosis is highly important. Several 
works have reported that osteoporosis is associated with the 
polymorphisms of some genes [9,10]. Analyses have revealed that 
 
vitamin D receptor (VDR), calcitonin receptor, Estrogen receptor 
(ER) gene, Type I collagen (COLIAI) gene, and Lactase (LCT) gene 
have the highest contribution to osteoporosis expansion [11]. 
Mineral homeostasis and bone metabolism are totally dependent on 
vitamin D. This vitamin plays its role through its receptor and vitamin 
D receptor (VDR) gene determines receptor structure. Therefore, 
VDR gene could be an important candidate gene for osteoporosis 
[12]. Gene mutation could influence function and be associated 
with potential development of osteoporosis [13]. Although a 
strong association has been offered between VDR genotypes 
and bone mineral density (BMD) in osteoporosis [14], inconsistent 
findings have been obtained on the possible association between 
postmenopausal bone loss and VDR genotype [12,15]. VDR gene is 
located on long arm of chromosome 12 (12q12-14). 10 exons and 
8 interons have been determined on this gene’s structure [16]. VDR 
polymorphisms consist of FokI, ApaI, BsmI, TaqI, Cdx2, etc [17].
The ApaI polymorphism (rs7975232) is located on interon 8. This 
polymorphism causes guanine nucleotide to be substituted with 
thymine (G→T) [18]. In the TaqI polymorphism, the nucleotide at 
position 352 is converted from thymine into cytosine (T352C). 
Therefore, ATT codon which encodes isoleucine is converted into 
the codon of another isoleucine, i.e. ATC [19,20]. In the VDR gene, 
the ability to cut by the ApaI and TaqI enzymes leads to development 
of other genotypes as follows:
The genotypes of ApaI: AA (absence of the position identifying the 
enzyme); Aa (heterozygous position of identifying the enzyme), 
and aa (existence of the position identifying the enzyme) and the 
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Introduction: Vitamin D receptor gene is one of candidate 
genes related to osteoporosis expansion. The association of 
ApaI, TaqI, BsmI polymorphisms in vitamin D receptor gene with 
bone metabolism and density has been area of interest in many 
studies. 
Aim: This study was conducted to further investigate the 
association between the ApaI, TaqI, BsmI polymorphisms and 
bone density. This study was analytical study. Centers for bone 
density measurement in southwestern Iran.
Materials and Methods: In this analytical study, 200 participants 
aged 45- and above 45-year-old women referring the centers of 
bone density measurement participated. The bone density of 
femoral neck and lumbar vertebrae was measured using dual-
energy X-ray absorptiometry method. Based on t-score, the 
participants were assigned into patients (n=130) and healthy 
individuals (n=70). Different genotypes of ApaI (AA/Aa/aa), 
TaqI (TT/Tt/tt), and BsmI (BB/Bb/bb) were determined by PCR-
RFLP.
The data on bone density and PCR-RFLP were analysed by chi-
square and ANOVA. Also, triad combination of the genotypes 
was statistically analysed. For each genotype combination, chi-
square was run between the patients and control group and 
p-value was calculated.
results: No significant association was seen between ApaI 
polymorphism and bone density (p>0.05). TaqI and BsmI 
polymorphisms had a significant association with femoral 
neck’s bone density (p<0.05), but these polymorphisms were 
not significantly associated with lumbar vertebrae’s (p>0.05). 
Patients with homozygous dominant TT genotype had the least 
bone density in femoral neck compared to other genotypes. 
Lumbar vertebrae’s bone density was similar in three TaqI 
genotypes. The patients with homozygous recessive bb 
genotype had the least bone density in femoral neck and lumbar 
vertebrae compared to other genotypes.
conclusion: TaqI and BsmI polymorphisms could be desirable 
markers in diagnosis of women at risk of osteoporosis in the 
studied region in Iran. Therefore, these women will receive 
suitable medical treatment at proper time. 
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genotypes of TaqI: TT (absence of the position identifying the 
enzyme); Tt (heterozygous position of identifying the enzyme), and 
tt (existence of the position identifying the enzyme).
The BsmI polymorphism (rs1544410) is located on interon 8 of VDR 
gene. In this polymorphism, the nucleotide adenine is substituted 
with guanine (A→G) [18].
The relationship between the VDR genotypes and BMD may be 
different in various racial and geographical populations [21,22]. This 
study was conducted to investigate the association between the 
ApaI, TaqI, and BsmI polymorphisms and bone density in 45 and 
over 45 year-old women in southwestern Iran.
MAterIAlS And MethOdS
In this analytical study, blood samples were taken from 45- and over 
45-year-old women referring centers for bone density measurement 
in southwestern Iran based on convenience sampling. In this 
study, based on Cockran formula 200 participants (130 patients 
and 70 healthy individuals) were investigated after their consent 
was obtained. Exclusion criteria were curtin consumption history, 
ovariectomization or premature ovarian failure, thyroid disease, 
calcium intake disorders, gastrointestinal and renal diseases and 
other diseases demonstrated to be associated with osteoporosis.
The bone density rate in lumbar vertebrae and femoral neck was 
measured by dual-energy X-ray absorptiometry (DEXA) method 
using Hologic QDR (Germany) and the values were determined 
by t-score. Then a 5 ml complete blood was taken for genetic 
examinations and collected in the tubes containing EDTA Anti-
coagulation. The samples were kept at 20°C till the day of tests.
The genomic DNA was extracted using phenol-chloroform method. 
The polymorphisms of ApaI, TaqI and BsmI were amplified from 
VDR gene using the primers designed by Gene Runner Software. 
The used primers are shown in [Table/Fig-1].
The materials in PCR reaction were as follows: 0.2 ml 10X buffer, 1.5 
µl 50mM MgCl2, 10 mM dNTP (2'-deoxynucleoside 5'-triphosphate) 
Mix, 0.7 µliter 10 pmol/ml forward primer, 0.7 µl10 pmol/ml reverse 
primer, 0.2 µl of Taq polymerase (5 U/µl), 3.2 µliters of template 
DNA, and ddH2O till the reaction volume reaches 25 µl. 
PCR reactions were done for ApaI and TaqI using the temperature 
gradient as follows:
95°C for 5 min as initial denaturation followed by 95°C for 50 
seconds, 68.7°C for 45 seconds as the connection point, 72°C for 
1 min as a 36-cycle extension, and finally 72°C for 5 min as final 
extension.
PCR reaction was done for BsmI per touchdown PCR using the 
temperature gradient as follows: 95°C for 3 min as initial denaturation 
followed by 95°C for 30 seconds, 56°C for 40 seconds and 72°C 
for 30 seconds for 8-cycle proliferation, and then 95°C for 40 
seconds, 49°C for 40 seconds and 72°C for 30 seconds for 26-
cycle amplification, and finally 72°C for 5 min as final extension. 
Thermocycler (ASTEC, PC818 Japan) was used. 
After amplification, the fragments were digested using ApaI, TaqI, 
and BsmI restriction enzymes (Fermentas). 
The RFLP reaction for each of the polymorphisms (for 30-µl volume) 
were as follows:  17.5µl sterile water, 2µl 10X buffer, 10µl PCR 
product, and 0.5µl restriction ApaI, TaqI and MVa12691 (BsmI) 
enzymes. Then, they were left at 37°C. The obtained products were 
reviewed on an 8% polyacrylamide gel and the genotype of ApaI, 
TaqI and BsmI were determined. 
StAtIStIcAl AnAlySIS
The data on bone density and PCR-RFLP were analysed by chi-
square and ANOVA. Also, triad combination of the genotypes was 
statistically analysed. For each genotype combination, chi-square 
was run between the patients and control group and p-value was 
calculated. 
reSultS
In 200 samples there were 737 bp amplified fragments for ApaI 
polymorphism, which produced two 520-bp and 217-bp fragments 
after digestion with ApaI enzyme if the position of restriction site was 
present [Table/Fig-2].
The length of amplified fragment in TaqI was 737 bp and the 
fragments below were produced due to the presence of a mandatory 
secondary position of identifying the enzyme in normal conditions: 
the TT genotype produced two 494-bp and 243-bp fragments, Tt 
four 494-bp, 243-bp, 201-bp, and 293-bp fragments, and tt three 
243-bp, 201-bp, and 293-bp fragments [Table/Fig-3].  
The BsmI enzyme cut the samples with b allele (the bb genotype) 
and produced two 192-bp and 166-bp fragments. The samples 
with BB genotype remained unchanged and had a 358-bp band, 
and those with Bb genotype had 192-bp, 166-bp, and 358-bp 
fragments [Table/Fig-4].
In the patients, the frequency distribution of ApaI genotypes was 79 
(60.8%) individuals with Aa, followed by AA in 50 (38.5%) and aa in 
one (0.7%). In the control group it was 41 (58.6%) individuals with 
[table/Fig-1]: The primers used.
[table/Fig-2]: The association of ApaI, TaqI, and BsmI polymorphisms with t-score 
in the patients.
polymorphism
the size
of fragment
Primer type 5´-3´ Primer sequences
ApaI 737
F CAGAGCATGGACAGGGAGCAA
R TCATGGCTGAGGTCTCAAGGG
TaqI 737
F CAGAGCATGGACAGGGAGCAA
R TCATGGCTGAGGTCTCAAGGG
BsmI 358
F GGGAGACGTAGCAAAAGG
R AGAGGTCAAGGGTCACTG
polymorphism
the patients’ 
genotype
number
Femoral neck’s 
t-score
Mean±SD 
Lumbar 
vertebrae’s 
t-score
Mean±SD 
ApaI
polymorphism
AA 50 -1.29±0.34 -2.75±0.83
Aa 79 -1.3±0.55 -2.83±0.50
aa 1 -2.1±0 -2.9±0
p-value 0.269 0.797
TaqI
polymorphism
TT 57 -1.43±0.48 -2.80±0.47
Tt 66 -1.2±0.48 -2.80±0.68
tt 7 -1.27±0.35 -2.80±1.38
p-value 0.025 0.999
BsmI
polymorphism
BB 31 -1.14±0.26 -2.92±0.78
Bb 70 -1.3±0.52 2.68±0.61
bb 29 -1.48±0.53 -2.94±0.53
p-value 0.025 0.091
Aa, followed by AA in 26 (37.1%) and aa in 3 (4.3%). By statistical 
analyses, there was no significant association between ApaI 
polymorphism and bone density rate in femoral neck and lumbar 
vertebrae (p<0.05). In the patients, the frequency distribution of TaqI 
genotypes was 66 (50.8%) individuals with Tt, followed by TT in 
57 (43.8%) and tt in seven (5.4%). In the control group it was 34 
(48.5%) individuals with TT, followed by Tt in 30 (42.9%) and tt in 6 
(8.6%). By statistical analyses, there was a significant association 
between TaqI polymorphism and bone density rate in femoral neck 
(p<0.05) and no significant association between TaqI polymorphism 
and bone density rate in lumbar vertebrae (p>0.05). The individuals 
with the homozygous dominant TT genotype had the lowest femoral 
neck’s bone density rate and lumbar vertebrae’s was the same in 
all genotypes.
In the patients, the frequency distribution of BsmI genotypes was 
70 (53.8%) individuals with Bb, followed by BB in 31 (23.8%) and 
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bb in 29 (22.3%). In the control group it was 39 (55.7%) individuals 
with Aa, followed by AA in 14 (20%) and aa in 17 (24.3%). By 
statistical analyses, there was a significant association between 
BsmI polymorphism and bone density rate in femoral neck (p<0.05) 
and no significant association between this polymorphism and bone 
density rate in lumbar vertebrae (p>0.05). The individuals with the 
homozygous recessive Bb genotype had a lower bone density rate 
in femoral neck and lumbar vertebrae compared to the genotypes 
Bb and BB [Table/Fig-5].
The results of sequence of polymorphic position are shown in 
[Table/Fig-6-8]. For ApaI polymorphism, substitution of guanine with 
thymine removes the restriction site completely in AA genotype. For 
[table/Fig-3]: The comparion of the genotypic combinations between the control group and the patients.
genotypic 
combination
t- score of the 
patients’ femoral 
neck
t- score of the 
patients’ lumbar 
vertebrae
the observed 
number/ patients
the expectednumber/ 
patients
the observed 
number/ controls
the expected 
number/ controls
Chi-Square p-value
AABBTt -1.1±0.19 -3.02±0.56 18 12 6 12 6 p<0.05
AABBtt -1.27±0.49 -2.9±1.92 4 4 4 4 0 p<0.05
AABbTT -1.6±0.43 -2.61±0.44 7 6 5 6 0.32 p<0.05
AABbTt -1.41±0.32 -2.35±0.86 15 10.5 6 10.5 3.86 p<0.05
AAbbTT -1.24±0.34 -3.04±0.67 5 4 3 4 0.5 p<0.05
AaBBTt -1.16±0.17 -2.76±0.41 6 4 2 4 2 p<0.05
AaBbTT -1.34±0.38 -2.64±0.34 19 15 11 15 2.14 p<0.05
AaBbTt -1.14±0.68 -2.9±0.59 27 21 15 21 3.42 p<0.05
AaBbtt -1.3±0 -2.9±0 1 1.5 2 1.5 1.4 p<0.05
AabbTT -1.51±0.56 -2.92±0.52 23 16.5 10 16.5 5.2 p<0.05
[table/Fig-4]: Polyacrylamide gel of the PCR-RFLP relevant to ApaI genotypes. The 737 bp fragment was seen for AA and Aa genotypes. The 520-bp and 217-bp fragments 
were seen after digestion with ApaI enzyme for Aa and aa genotypes. C+  and C- are abbreviation for control positive and control negative, respectively. Control positive and PCR 
show the 737 bp original amplified fragment. Control negative does not show any band as expected. 
[table/Fig-5]: Polyacrylamide gel of the PCR-RFLP relevant to TaqI genotypes. The TT genotype produced two 494-bp and 243-bp fragments. Tt genotype produced four 
494-bp, 243-bp, 201-bp, and 293-bp fragments, and tt one produced three 243-bp, 201-bp, and 293-bp fragments. C+  and C- are abbreviation for control positive and control 
negative, respectively. Control positive and PCR show the 737 bp original amplified fragment. Control negative does not show any band as expected. 
[table/Fig-6]: Polyacrylamide gel of the PCR-RFLP relevant to BsmI genotypes. The bb genotype produced two 192-bp and 166-bp fragments. The BB genotype had a 358-bp 
band, and the Bb genotype had 192-bp, 166-bp, and 358-bp fragments. C+  is abbreviation for control positive. Control positive shows the 358 bp original amplified fragment. 
[table/Fig-7]: The results of DNA sequencing for ApaI polymorphism The results of sequence determination indicated that G→T occurred in heterozygous Aa individuals (GT), 
but this conversion did not occur in homozygous aa individuals. 
[table/Fig-8]: The results of DNA sequencing for TaqI polymorphism. The results of sequence determination indicated that T→C occurred in heterozygous Tt individuals (TC), 
but this conversion did not occur in homozygous tt individuals (TT).
[table/Fig-9]: The results of sequence for BsmI polymorphism. (The results of sequence determination indicated that G→A occurred in both heterozygous Bb individuals (GA) 
and homozygous BB individuals (AA).
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TaqI polymorphism, conversion of thymine into cytosine leads to 
generation of a restriction site in tt genotype. For BsmI polymorphism, 
substitution of adenine with guanine produces a restriction site in bb 
genotype. 
the results of triad combination: 11 genotypic combinations 
were common between the patients and the control group. In view 
of p-value, there was a significant difference in frequency of only 
AABBTt, AABbTt, and AabbTT between the control group and the 
patients (p<0.05). The individuals with AABbTt genotype had the 
highest bone density rate of lumbar vertebrae in the patients and 
those with AabbTT had the least bone density rate of femoral neck 
in the patients [Table/Fig-9]. 
dIScuSSIOn
Osteoporosis is a serious, metabolic bone disorder. Osteoporosis 
expansion can be related to VDR gene polymorphisms, including 
ApaI, TaqI and BsmI polymorphisms. This study indicated that 
there was no significant association between ApaI polymorphism 
and bone density rate in lumar vertebrae and femoral neck; TaqI 
and BsmI polymorphisms were significantly associated with femoral 
neck’s bone density rate, but not significantly associated with lumbar 
vertebrae’s. In addition, the patients with homozygous recessive bb 
genotype had a lower bone density rate in femoral neck and lumbar 
vertebrae compared to the genotypes Bb and BB.
In similar works by Qin et al., on the association of different 
polymorphisms of VDR gene and estrogen receptor alpha with bone 
density in postmenopausal women, no significant association was 
noted between ApaI polymorphism and bone density in femoral 
neck and lumbar vertebrae [23]. Zajickova et al., investigated the 
association of BsmI, ApaI and TaqI polymorphisms with bone density 
in 114 Czech postmenopausal women with mean age of 62.5±8.9 
years. They argued that there was no significant association 
between these polymorphisms and bone density in any skeletal site 
and no significant difference in genotypic distribution was observed 
between the patients and the control group [24]. Uysal et al.,  also 
examined the association between BsmI, ApaI, and TaqI and 
osteoporosis in 246 postmenopausal women in Turkey and found 
no significant association between ApaI and TaqI polymorphisms 
and osteoporosis [25]. Shen et al., indicate that ApaI, BsmI, TaqI 
and FokI polymorphisms may be not associated with the risk of 
fracture in postmenopausal women [26]. But, Mitra et al., examined 
246 Indian postmenopausal women with mean age of 54.2±3.4-
year-old and reported mean bone density in spine and femoral 
neck of the women with homozygous recessive AA genotype and 
homozygous dominant TT genotype was 10% higher than that of 
the women with the genotypes AA and tt [21].
Tamulaitiene et al., reported similar findings to those on BsmI 
polymorphism obtained in the present study. They stated there was no 
significant difference in the frequency of BsmI genotypes between the 
patients and the control group. Also, the BsmI polymorphism of VDR 
gene had a non significant, weak association with BMD and severe 
postmenopausal osteoporosis, which needed further investigations. 
In the patients with severe osteoporosis, the bone density of the 
individuals with the BB genotype was higher compared to those with 
the genotypes Bb and bb [27]. But, Ji et al., in a meta-analysis found 
that in the Caucasian cases with osteoporosis-related fracture, the 
frequency of homozygous recessive bb genotype was significantly 
lower [28]. Also, Garnero et al., indicated an association between 
the increase in B allele and fracture frequency. The relative risk of 
such fractures in the women with heterozygous Bb genotype was 
1.5 times higher and in the women with the homozygous dominant 
BB genotype was 2.1 times higher compared to the women carrying 
homozygous recessive bb genotype [29].
Langdahl et al., investigated the BsmI, ApaI, and TaqI 
polymorphisms in 192 patients with osteoporosis and 207 healthy 
controls in Denmark and found the genotypes BB and Bb were 
higher. Femoral neck’s BMD was higher in the individuals with Bb 
genotype. They concluded that B allele of BsmI polymorphism was 
associated with decrease in bone density and the fractures due 
to osteoporosis [30]. Thakkinstian et al., did an extensive analysis 
on the association between BsmI polymorphism of VDR gene and 
bone density and found that B allele was significantly associated 
with lumbar vertebrae’s bone density and also the individuals with 
the BB genotype had a lower bone density compared to those with 
the genotypes Bb and bb [31]. 
When comparing genotypes in the patients individually, the Aa 
genotype of ApaI polymorphism had a bone density approximately 
similar to that of the AA genotype. For TaqI polymorphism in the 
patients, Tt genotype was similar to the two other genotypes 
in view of lumbar vertebrae’s bone density and between the two 
other genotypes (TT, tt) in view of femoral necks. Therefore, since 
frequency of the genotypic combination AABbTt is low (15 of 130) 
in the patients, this combination could represent less likelihood of 
fracture in the individuals with this genotype compared to other 
patients.
In addition, of the three above-mentioned genotypic combinations, 
the individuals with genotypic combination of AabbTT had the lowest 
bone density of femoral neck and this genotypic combination was 
observed in 23 patients. When comparing the genotypes of each 
polymorphism individually, we observed that the Bb genotype of 
BsmI polymorphism and TT genotype of TaqI polymorphism had 
the lowest bone density of femoral neck compared to other relevant 
genotypes. Therefore, simultaneous study of two polymorphisms 
is more valuable than studying them separately, but the genotypes 
related to ApaI polymorphism seem to yield little data on genotypic 
combinations. The same could be concluded for examining this 
polymorphism separately. 
cOncluSIOn
The study of genotypic combination of three polymorphisms does 
not yield the data inconsistent with those of studies on individual 
polymorphisms and simultaneous study of three polymorphisms 
could yield better data compared to study of individual 
polymorphisms. TaqI and BsmI polymorphisms could be good 
markers in identifying the women predisposed to osteoporosis in 
the region and even Iran, however larger and/or other populations 
need to be investigated to confirm these findings.
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